Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) is a house keeping enzyme which catalyzes the first step in the hexose monophosphate pathway of glucose metabolism. G6PD deficiency is the commonest hemolytic X-linked genetic disease, which affects approximately 400 million people worldwide. The prevalence rate of G6PD deficiency varies worldwide with a higher prevalence in malarial endemic population. In India several studies were published and reported with varying incidences of this disease in different populations.
Introduction
Glucose 6-phosphate dehydrogenase (G6PD) deficiency was discovered half a century ago and is still the most common inherited enzymopathy. Clinically, deficiency of this enzyme affects as many as 400 million individuals worldwide [1] . This inherited deficiency causes neonatal hyperbilirubinemia and chronic hemolytic anemia. Although most affected individuals are asymptomatic, exposure to oxidative stresses such as certain drugs or infection, can elicit acute hemolysis. G6PD deficiency was first identified in American blacks (African and Asian descent) in the course of studies of sensitivity to the hemolytic effect of primaquine [2] . Soon after G6PD deficiency was also reported from Mediterranean populations and it became apparent that the enzyme deficiency in the Mediterranean population was much more severe than the prototype deficiency that had been found in American blacks [3] . In 1986, the G6PD gene was cloned independently by Persico et al. [4] and Takizawa et al. [5] . G6PD gene is located on the long arm of the X chromosome (Xq28), and consists of 13 exons [6] . G6PD locus is thought to be one of the most polymorphic loci among humans with almost 300 allelic variants reported [7] . The G6PD enzyme monomer consists of 515 residues with over 59 kDa molecular weight. It was reported that the enzymatically active form of G6PD is either a dimer or tetramer of a single polypeptide subunit according to cellular pH [8] .
Methods

Searched strategy and identification of studies
For the present meta-analysis PubMed, Science Direct, Springer link and Google scholar databases were searched for suitable articles using keywords ''G6PD deficiency" and ''Glucose 6 phosphate dehydrogenase deficiency". Since the retrieved article list was too long only the studies carried out in India were taken into consideration. The included articles were also hand searched for additional studies which can be included in this study.
Inclusion and exclusion criteria
The inclusion criteria for the studies were as follows: studies: (1) should be original and published, (2) that used only Indian samples. Studies were excluded if they were: (1) molecular analyses, (2) case reports, and (3) reviews and editorials.
Data extraction
From all the eligible studies the following information was extracted: first authors' family name, year of publication, population/ethnic group, the number of samples analyzed, the number of G6PD deficient subjects and journal name. If in any study samples were taken from multiple caste/race then information was abstracted separately for each caste.
Statistical analysis
Prevalence proportion (PP) was computed from the number of deficient and sample sizes (N) with the corresponding 95% confidence interval (CI) from each study. A pooled PP was then estimated on the basis of the individual PPs. The PP was estimated either by using fixed effects [9] or random effects [10] model depending upon heterogeneity. The heterogeneity between studies was tested using the Q-statistics and quantified using the I 2 statistic [11] . If I 2 > 50% then random effect model was used [12] . Publication bias was investigated by using the funnel plots. All p values are two tailed with a significance level at 0.05. All statistical analyses were undertaken by computer program Meta-analyst. 
Results
The preliminary search resulted in 243 publications from PubMed, Google scholar, Science Direct, and Springer Link. Out of which 124 were irrelevant for the present metaanalysis, which includes reviews, editorials, book chapters, case reports, etc. After initial exclusion of 124 articles, total 117 articles remained. Out of which, in 52 articles molecular analyses were carried out, 23 articles reported overlapping data and 9 were not from India. Thus, a total of 33 articles were included in present meta-analysis. The search workflow was shown in Fig. 1 . Study characteristics were summarized in Table 1 . Thirtythree articles that reported G6PD deficiency from different parts of India were found suitable for the inclusion in the present meta-analysis . All studies were published between the periods of 1961 and 2014. A few authors studied several different caste populations, so each population was included as an individual study. A total of 72 populations were studied in thirty-three articles. All these thirty-three studies were performed in different states of the India, Maharashtra [16, 17, 23, 29] , West Bengal [25, 29, 36] , Orissa [14, 20, 21, 30, 35] , Punjab [44] , Rajasthan [27] , Madhya Pradesh [30] , Western India [27] , Central Eastern India [15] , Uttar Pradesh [32, 37, 38, 44] , Andaman and Nicobar [35] , Haryana [41] , Gujarat [26] , New Delhi [42] , Mizoram [22] , Jammu and Kashmir [18] , Nagaland [18] , Karnataka [18] , Kerala [18] , Assam [18] , Andhra Pradesh [43] , Dadra and Nagar Haveli [24, 40] , Manipur [13] , and Himachal Pradesh [29] .
In thirty-three studies included in the present meta-analysis, the smallest sample size was 29 [35] , and highest sample size was 9,433 [27] . Totally 8,565 samples were analyzed, out of which 2,626 individuals were G6PD deficient.
Meta-analysis was performed using both fixed and random effect models. Meta-analysis with Fixed effects model showed 0.096 (95% CI = 0.093-0.100) (Fig. 2) . Meta-analysis with random effect model showed an overall prevalence proportion as 0.087 (95% CI = 0.070-0.103; p = 0.000; tau = 0.826; I 2 = 0.486; Cochran Q = 0.999) (Fig. 3) . Publication bias was absent (Fig. 4) .
Discussion
According to World Health Organization [48] the prevalence of G6PD deficiency in India ranges 0-10% which is population specific and is reported to be higher among tribals in comparison to caste population [49] . In general, the frequency of G6PD deficient allele is comparatively higher in North and West India, which indicates considerable stability of the allele in these areas, whereas in South India it is uniformly low except in Andhra Pradesh and Tamil Nadu. Bhasin [18] reported the distribution of G6PD deficient (Gd À ) allele according to natural regions, climatic regions, Himalayan regions, and different ethnic groups. In the Himalayan region, the frequency is quite high (0.087) as compared to non-Himalayan region (0.043) and frequency of G6PD deficient allele in scheduled tribes is high (0.055) as compared to other ethnic groups. Several reports regarding the frequency of G6PD deficient (Gd À ) allele was published from all the states and also in several caste groups like-Parsee [17] , Muslim [13] , Brahmin [13, 29, 42, 43, 50] , Jat [42] , Rajputs [24, 29, 31, 50] , and Scheduled caste [38, 46] . Bhasin [9] reviewed that G6PD deficiency in India varies from 1% to 27% in different communities and regions of India. The review shows varying frequencies in different regions and ethnic groups depending upon the hyperendemicity of malaria. In eastern India, the frequency is the highest in Angami Nagas (27.1%), followed by Adi (19.4%), Apatani (16.7%), Nishi (16%), Rabha (15.8%), Mikir (15.6%), Santhal (14.1%), etc. [51] . In western India, higher frequency is found in the Vataliya Prajapati (caste) community (27.9%), Gonds (24.4%), Warli (19.5%), Parsis (15.7%), Madia (14.4%), Kutchi Bhanushalis (13%), etc. In the North, high frequency has been shown in Meghwal-Chamars (15.1%) and Punjabi Khatris (14%) for this defective enzyme. In South India, high incidence of G6PD deficiency is found in the tribals Figure 2 Forest plot of prevalence proportion of fixed effect model. Glucose-6-phosphate dehydrogenase deficiency in India(13%) of Andhra Pradesh and Kurumba tribe (11.9%) of Kerala [51] . The frequency of G6PD deficiency in Dhelki Kharia subtribe (30.4%) is the highest so far reported from India.
As an important statistical method developed recently, meta-analysis quantitatively combines several small analysis of the same topic with low statistical power and small number of participants and with a homogeneous design. Because of the large sample sizes, meta-analysis has more statistical power than a single study to obtain reliable results. Several metaanalysis studies were already published, which investigated effects of gene variants in disease causing or prevalence proportion of pathogenic variants in different populations to assess small effect of MTHFR C677T polymorphism as risk factor for different diseases [52, 53] .
Early detection and prevention is the key strategy for the successful management and control of G6PD deficiency. The G6PD deficient individuals are asymptomatic (until they are exposed to oxidative stress) so they transmit pathogenic mutated gene to the next generation. In addition, G6PD deficiency carriers are partially protected against malarial infection hence this mutation is naturally selected in malarial endemic regions of India. The results of the present metaanalysis determined the exact magnitude of the G6PD defi- Figure 3 Forest plot of prevalence proportion of random effect model. ciency in Indian population i.e. 8.5%, which can aid in planning programs to improve neonatal health and also help to plan the strategy to successful management and control of this genetic disorder.
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